R3 Stem Cell Issues Statement Regarding FDA Warning Letter
R3 Stem Cell Issues Statement Regarding FDA Letter, clarifying no product recalls ever performed, no reported patient harm, and treatment disclosures present. SCOTTSDALE, AZ, UNITED STATES, November 5, 2026 /EINPresswire.com/ -- R3 Stem Cell, one of …